Epidemiological characteristics of severe skin adverse reactions caused by immune checkpoint inhibitors based on case reports
Healthcare professionals must remain vigilant for severe cirAEs and ensure timely diagnosis and management to safeguard patient safety during ICI therapy.
Authors
- Na-na Chen
- Xiaowen Ma (ORCID: https://orcid.org/0000-0003-3574-4440)
- Na-na Zhang
- Ping Yang
- Xiao-yan Zhang
- Su-na Tang
- Feng-lin Ye
- Fei Wang
- Ning-ning Zhu
Publication Details
- Journal
- International Journal of Clinical Pharmacology and Therapeutics
- Published
- 2026-01-26
- DOI
- https://doi.org/10.5414/cp204826
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00